Evidence map›Paper›PMID 34475438›Full record

Trial reportScientific reports2021

Increased vulnerability to SARS-CoV-2 infection among indigenous people living in the urban area of Manaus.

Gemilson Soares Pontes, Jean de Melo Silva, Renato Pinheiro-Silva, Anderson Nogueira Barbosa, Luciano Cardenes Santos, Antônio de Pádua Quirino Ramalho, Carlos Eduardo de Castro Alves, Danielle Furtado da Silva, Leonardo Calheiros de Oliveira, Allyson Guimarães da Costa and 1 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Gemilson Soares PontesLaboratório de Imunologia e Virologia, Instituto Nacional de Pesquisas da Amazônia (INPA), Coordenação Sociedade, Ambiente e Saúde, Av. André Araújo, 2936-Petrópolis, Manaus, Amazonas, CEP 69.067-375, Brazil. gemilson.pontes@inpa.gov.br.
Jean de Melo SilvaUniversidade Federal do Amazonas (UFAM), Programa de Pós-Graduação em Imunologia Básica e Aplicada, Manaus, Brazil.
Renato Pinheiro-SilvaUniversidade do Estado do Amazonas, Programa de Pós-Graduação em Ciências Aplicadas à Hematologia, Manaus, Brazil.
Anderson Nogueira BarbosaLaboratório de Imunologia e Virologia, Instituto Nacional de Pesquisas da Amazônia (INPA), Coordenação Sociedade, Ambiente e Saúde, Av. André Araújo, 2936-Petrópolis, Manaus, Amazonas, CEP 69.067-375, Brazil.
Luciano Cardenes SantosUniversidade Federal do Mato Grosso, Campus do Araguaia, Barra das Garças, Mato Grosso, Brazil.
Antônio de Pádua Quirino RamalhoDepartamento de Saúde Coletiva, Universidade Federal do Amazonas (UFAM), Faculdade de Medicina, Manaus, Brazil.
Carlos Eduardo de Castro AlvesUniversidade Federal do Amazonas (UFAM), Programa de Pós-Graduação em Imunologia Básica e Aplicada, Manaus, Brazil.
Danielle Furtado da SilvaInstituto Nacional de Pesquisas da Amazônia (INPA), Programa de Pós-Graduação em Biodiversidade e Biotecnologia da Amazônia Legal-PPG-BIONORTE, Manaus, Brazil.
Leonardo Calheiros de OliveiraUniversidade do Estado do Amazonas, Programa de Pós-Graduação em Ciências Aplicadas à Hematologia, Manaus, Brazil.
Allyson Guimarães da CostaUniversidade Federal do Amazonas (UFAM), Programa de Pós-Graduação em Imunologia Básica e Aplicada, Manaus, Brazil.
Ana Carla BrunoLaboratório de Imunologia e Virologia, Instituto Nacional de Pesquisas da Amazônia (INPA), Coordenação Sociedade, Ambiente e Saúde, Av. André Araújo, 2936-Petrópolis, Manaus, Amazonas, CEP 69.067-375, Brazil.
Universidade Federal do Amazonas · BRNational Institute of Amazonian Research · BRUniversidade do Estado do Amazonas · BRUniversidade Federal de Mato Grosso · BR

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior PROCAD AMAZÔNIA 88881.200581/201801Fundação de Amparo à Pesquisa do Estado do Amazonas FAPEAM-Pró-Estado Program
6 · The paper itself

Abstract

The COVID-19 pandemic threatens indigenous peoples living in suburban areas of large Brazilian cities and has thus far intensified their pre-existing socio-economic inequalities. We evaluated the epidemiological situation of SARS-CoV-2 infection among residents of the biggest urban multiethnic indigenous community of the Amazonas state, Brazil. Blood samples of 280 indigenous people living in the surrounding area of Manaus were tested for the presence of anti-SARS-CoV-2 IgA or IgG antibodies. The risk factors and sociodemographic information were assessed through an epidemiological questionnaire. We found a total positivity rate of 64.64% (95% CI 59.01-70.28) for SARS-CoV-2 infection. IgA and IgG were detected in 55.71% (95% CI 49.89-61.54) and 60.71% (95% CI 54.98-66.45) of the individuals, respectively. Over 80% of positive individuals were positive for both IgA and IgG.No significant difference in positivity rates between genders or age groups was observed. Moreover, the age group ≥ 60 years old showed the highest antibody ratios (IgA mean ratio = 3.080 ± 1.623; IgG mean ratio = 4.221 ± 1.832), while the age groups 13-19 and 20-29 showed the lowest IgA (mean ratio = 2.268 ± 0.919) and IgG ratios (mean ratio = 2.207 ± 1.246), respectively. Individuals leaving the home more frequently were at higher risk of infection (Odds ratio (OD) 2.61; 95% CI 1.00-1.49; p = 0.048). Five or more individuals per household increased fivefold the risk of virus transmission (OR 2.56; 95% CI 1.09-6.01; p = 0.019). The disproportionate dissemination of SARS-CoV-2 infection observed among the study population might be driven by typical cultural behavior and socioeconomic inequalities. Despite the pandemic threat, this population is not being targeted by public policies and appears to be chronically invisible to the Brazilian authorities.

Indexed as

COVID-19COVID-19 Serological TestingIndigenous PeoplesPandemicsAdolescentAdultAntibodies, ViralBrazilFemaleHumansImmunoglobulin AImmunoglobulin GMaleMiddle AgedSARS-CoV-2Antibodies, ViralImmunoglobulin AImmunoglobulin G

Identifiers

PMID34475438
PMCPMC8413354
OpenAlexW3198094836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.